Back
Everi Holdings 10K Form
Sell
38
EVRI
Everi Holdings
Last Price:
13.44
Seasonality Move:
10.42%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2020-08-04 | 10Q | EVRI/Everi Holdings Quarterly |
2020-06-02 | 10Q | EVRI/Everi Holdings Quarterly |
2020-03-02 | 10K | EVRI/Everi Holdings Annual |
2019-11-05 | 10Q | EVRI/Everi Holdings Quarterly |
2019-08-06 | 10Q | EVRI/Everi Holdings Quarterly |
2019-05-07 | 10Q | EVRI/Everi Holdings Quarterly |
Receive EVRI News And Ratings
See the #1 stock for the next 7 days that we like better than EVRI
EVRI Financial Statistics
Sales & Book Value
Annual Sales: | $807.82M |
---|---|
Cash Flow: | $361.86M |
Price / Cash Flow: | 2.8 |
Annual Sales: | $2.92 |
Price / Book: | 4.61 |
Profitability
EPS (TTM): | 0.15000 |
---|---|
Net Income (TTM): | $13.05M |
Gross Margin: | $646.58M |
Return on Equity: | 5.44% |
Return on Assets: | 0.63% |
Everi Holdings Earnings Forecast
Key Everi Holdings Financial Ratios
- The Gross Profit Margin over the past 23 years for EVRI is 80.04%.
- The Selling, General & Administrative Expenses for EVRI have been equal to 0.00% of Gross Profit Margin.
- The Research & Development expenses have been 8.37% of Revenue.
- The Interest Expense is -39.77% of Operating Income.
- The Net Earning history of EVRI is 10.40% of Total Revenues.
- Per Share Earnings over the last 23 years have been positive in 11 years.
Everi Holdings Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NYSE |
---|---|
Industry: | Hotels, Restaurants & Leisure |
Sector: | Consumer Discretionary |
Current Symbol: | EVRI |
CUSIP: | 30034T |
Website: | everi.com |
Debt
Debt-to-Equity Ratio: | 3.86 |
---|---|
Current Ratio: | 1.06 |
Quick Ratio: | 0.91 |
Price-to-Earnings
Trailing P/E Ratio: | 14.77 |
---|---|
Forward P/E Ratio: | 18.8 |
EVRI Technical Analysis vs Fundamental Analysis
Sell
38
Everi Holdings (EVRI)
is a Sell
Is Everi Holdings a Buy or a Sell?
-
Everi Holdings stock is rated a Sell
The current Everi Holdings [EVRI] share price is $13.44. The Score for EVRI is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.